226 related articles for article (PubMed ID: 29632716)
1. Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression.
Lanuza PM; Vigueras A; Olivan S; Prats AC; Costas S; Llamazares G; Sanchez-Martinez D; Ayuso JM; Fernandez L; Ochoa I; Pardo J
Oncoimmunology; 2018; 7(4):e1395123. PubMed ID: 29632716
[TBL] [Abstract][Full Text] [Related]
2. Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy
Lanuza PM; Alonso MH; Hidalgo S; Uranga-Murillo I; García-Mulero S; Arnau R; Santos C; Sanjuan X; Santiago L; Comas L; Redrado S; Pazo-Cid R; Agustin-Ferrández MJ; Jaime-Sánchez P; Pesini C; Gálvez EM; Ramírez-Labrada A; Arias M; Sanz-Pamplona R; Pardo J
Front Immunol; 2022; 13():890836. PubMed ID: 35747143
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord blood CD34
Hoogstad-van Evert JS; Cany J; van den Brand D; Oudenampsen M; Brock R; Torensma R; Bekkers RL; Jansen JH; Massuger LF; Dolstra H
Oncoimmunology; 2017; 6(8):e1320630. PubMed ID: 28919991
[TBL] [Abstract][Full Text] [Related]
4. Physical Characterization of Colorectal Cancer Spheroids and Evaluation of NK Cell Infiltration Through a Flow-Based Analysis.
Sargenti A; Musmeci F; Bacchi F; Delprete C; Cristaldi DA; Cannas F; Bonetti S; Pasqua S; Gazzola D; Costa D; Villa F; Zocchi MR; Poggi A
Front Immunol; 2020; 11():564887. PubMed ID: 33424829
[TBL] [Abstract][Full Text] [Related]
5. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
Courau T; Bonnereau J; Chicoteau J; Bottois H; Remark R; Assante Miranda L; Toubert A; Blery M; Aparicio T; Allez M; Le Bourhis L
J Immunother Cancer; 2019 Mar; 7(1):74. PubMed ID: 30871626
[TBL] [Abstract][Full Text] [Related]
6. Human NK cells activated by EBV
Sánchez-Martínez D; Azaceta G; Muntasell A; Aguiló N; Núñez D; Gálvez EM; Naval J; Anel A; Palomera L; Vilches C; Marzo I; Villalba M; Pardo J
Oncoimmunology; 2015 Mar; 4(3):e991613. PubMed ID: 25949911
[TBL] [Abstract][Full Text] [Related]
7. Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling.
Varudkar N; Oyer JL; Copik A; Parks GD
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34172515
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.
Giannattasio A; Weil S; Kloess S; Ansari N; Stelzer EH; Cerwenka A; Steinle A; Koehl U; Koch J
BMC Cancer; 2015 May; 15():351. PubMed ID: 25933805
[TBL] [Abstract][Full Text] [Related]
9. Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors.
Chen Z; Yang Y; Liu LL; Lundqvist A
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31340613
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids.
Morimoto T; Nakazawa T; Matsuda R; Nishimura F; Nakamura M; Yamada S; Nakagawa I; Park YS; Tsujimura T; Nakase H
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638384
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.
Van Audenaerde JRM; De Waele J; Marcq E; Van Loenhout J; Lion E; Van den Bergh JMJ; Jesenofsky R; Masamune A; Roeyen G; Pauwels P; Lardon F; Peeters M; Smits ELJ
Oncotarget; 2017 Aug; 8(34):56968-56979. PubMed ID: 28915646
[TBL] [Abstract][Full Text] [Related]
12.
Shevtsov M; Pitkin E; Ischenko A; Stangl S; Khachatryan W; Galibin O; Edmond S; Lobinger D; Multhoff G
Front Immunol; 2019; 10():454. PubMed ID: 30967859
[TBL] [Abstract][Full Text] [Related]
13. Zoledronate Triggers Vδ2 T Cells to Destroy and Kill Spheroids of Colon Carcinoma: Quantitative Image Analysis of Three-Dimensional Cultures.
Varesano S; Zocchi MR; Poggi A
Front Immunol; 2018; 9():998. PubMed ID: 29867975
[TBL] [Abstract][Full Text] [Related]
14. Activated Allogeneic NK Cells Preferentially Kill Poor Prognosis B-Cell Chronic Lymphocytic Leukemia Cells.
Sánchez-Martínez D; Lanuza PM; Gómez N; Muntasell A; Cisneros E; Moraru M; Azaceta G; Anel A; Martínez-Lostao L; Villalba M; Palomera L; Vilches C; García Marco JA; Pardo J
Front Immunol; 2016; 7():454. PubMed ID: 27833611
[TBL] [Abstract][Full Text] [Related]
15. Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.
Terunuma H
J Stem Cells Regen Med; 2012; 8(3):205-6. PubMed ID: 24693200
[TBL] [Abstract][Full Text] [Related]
16. Contribution of natural killer cells in innate immunity against colorectal cancer.
Ghazvinian Z; Abdolahi S; Tokhanbigli S; Tarzemani S; Piccin A; Reza Zali M; Verdi J; Baghaei K
Front Oncol; 2022; 12():1077053. PubMed ID: 36686835
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells in the treatment of high-risk acute leukaemia.
Locatelli F; Moretta F; Brescia L; Merli P
Semin Immunol; 2014 Apr; 26(2):173-9. PubMed ID: 24613727
[TBL] [Abstract][Full Text] [Related]
18. New directions in natural killer cell-based immunotherapy of human cancer.
Farag SS; Fehniger TA; Becknell B; Blaser BW; Caligiuri MA
Expert Opin Biol Ther; 2003 Apr; 3(2):237-50. PubMed ID: 12662139
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 Mediates Dysfunction in Activated PD-1
Concha-Benavente F; Kansy B; Moskovitz J; Moy J; Chandran U; Ferris RL
Cancer Immunol Res; 2018 Dec; 6(12):1548-1560. PubMed ID: 30282672
[TBL] [Abstract][Full Text] [Related]
20. Low-doses of sequential-kinetic-activated interferon-γ enhance the ex vivo cytotoxicity of peripheral blood natural killer cells from patients with early-stage colorectal cancer. A preliminary study.
Radice E; Miranda V; Bellone G
Int Immunopharmacol; 2014 Mar; 19(1):66-73. PubMed ID: 24369312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
